Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mayuri Sharma

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
NPJ Vaccines|February 2, 2026
The TAK-003 story: key decisions that shaped development of a tetravalent dengue vaccineIan Escudero, Dieter Gniel, Shibadas Biswal, et al.
The Journal of Infectious Diseases|April 3, 2025
Anti-Dengue Virus Antibody Avidity Correlates with Protection Against Symptomatic Dengue Virus InfectionIsamu Tsuji, David Dominguez, Jonathan Hernandez, et al.
Expert Review of Vaccines|April 10, 2025
TAK-003: development of a tetravalent dengue vaccineXavier Sáez-Llorens, Rodrigo DeAntonio, Jenny Guek Hong Low, et al.
The Journal of Infectious Diseases|February 21, 2019
Magnitude and Functionality of the NS1-Specific Antibody Response Elicited by a Live-Attenuated Tetravalent Dengue Vaccine CandidateMayuri Sharma, Dustin R Glasner, Heather Watkins, et al.
Journal of Travel Medicine|January 13, 2026
Comment on: Pettersson et al. Qdenga-induced dengue caused by minor DENV-2 subvariant(s) in the vaccine, with two amino acid substitutions in the E proteinVianney Tricou, Jill Livengood, Mayuri Sharma, et al.
Journal of Virology|August 3, 2012
A mutation deleting sequences encoding the amino terminus of human cytomegalovirus UL84 impairs interaction with UL44 and capsid localizationBlair L Strang, Brian J Bender, Mayuri Sharma, et al.
The EMBO Journal|October 30, 2015
Unexpected features and mechanism of heterodimer formation of a herpesvirus nuclear egress complexMing F Lye, Mayuri Sharma, Kamel El Omari, et al.
Viruses|March 26, 2022
Human Cytomegalovirus Nuclear Egress Complex Subunit, UL53, Associates with Capsids and Myosin Va, but Is Not Important for Capsid Localization towards the Nuclear PeripheryAdrian R Wilkie, Mayuri Sharma, Margaret Coughlin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 9, 2026
Letter to Editor: Rattanaumpawan P, et al. Severe Dengue Hemorrhagic Fever After TAK-003 Dengue Vaccination: A Case Report of a Potential Vaccine-Associated Adverse ReactionVianney Tricou, Mayuri Sharma, Yin Xiang Setoh, et al.
Plos Medicine|October 24, 2025
Correction: Vaccination strategies, public health impact and cost-effectiveness of dengue vaccine TAK-003: A modeling case study in ThailandJing Shen, Elizaveta Kharitonova, Anna Tytula, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
NPJ Vaccines|February 2, 2026
The TAK-003 story: key decisions that shaped development of a tetravalent dengue vaccineIan Escudero, Dieter Gniel, Shibadas Biswal, et al.
The Journal of Infectious Diseases|April 3, 2025
Anti-Dengue Virus Antibody Avidity Correlates with Protection Against Symptomatic Dengue Virus InfectionIsamu Tsuji, David Dominguez, Jonathan Hernandez, et al.
Expert Review of Vaccines|April 10, 2025
TAK-003: development of a tetravalent dengue vaccineXavier Sáez-Llorens, Rodrigo DeAntonio, Jenny Guek Hong Low, et al.
The Journal of Infectious Diseases|February 21, 2019
Magnitude and Functionality of the NS1-Specific Antibody Response Elicited by a Live-Attenuated Tetravalent Dengue Vaccine CandidateMayuri Sharma, Dustin R Glasner, Heather Watkins, et al.
Journal of Travel Medicine|January 13, 2026
Comment on: Pettersson et al. Qdenga-induced dengue caused by minor DENV-2 subvariant(s) in the vaccine, with two amino acid substitutions in the E proteinVianney Tricou, Jill Livengood, Mayuri Sharma, et al.
Journal of Virology|August 3, 2012
A mutation deleting sequences encoding the amino terminus of human cytomegalovirus UL84 impairs interaction with UL44 and capsid localizationBlair L Strang, Brian J Bender, Mayuri Sharma, et al.
The EMBO Journal|October 30, 2015
Unexpected features and mechanism of heterodimer formation of a herpesvirus nuclear egress complexMing F Lye, Mayuri Sharma, Kamel El Omari, et al.
Viruses|March 26, 2022
Human Cytomegalovirus Nuclear Egress Complex Subunit, UL53, Associates with Capsids and Myosin Va, but Is Not Important for Capsid Localization towards the Nuclear PeripheryAdrian R Wilkie, Mayuri Sharma, Margaret Coughlin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|February 9, 2026
Letter to Editor: Rattanaumpawan P, et al. Severe Dengue Hemorrhagic Fever After TAK-003 Dengue Vaccination: A Case Report of a Potential Vaccine-Associated Adverse ReactionVianney Tricou, Mayuri Sharma, Yin Xiang Setoh, et al.
Plos Medicine|October 24, 2025
Correction: Vaccination strategies, public health impact and cost-effectiveness of dengue vaccine TAK-003: A modeling case study in ThailandJing Shen, Elizaveta Kharitonova, Anna Tytula, et al.
Pageof 4